Daniel Van Plew
2021
In 2021, Daniel Van Plew earned a total compensation of $8.8M as Executive Vice President and General Manager, Industrial Operations and Product Supply at Regeneron Pharmaceuticals, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $930,587 |
|---|---|
| Option Awards | $4,199,871 |
| Salary | $822,800 |
| Stock Awards | $2,799,882 |
| Other | $20,950 |
| Total | $8,774,090 |
Van Plew received $4.2M in option awards, accounting for 48% of the total pay in 2021.
Van Plew also received $930.6K in non-equity incentive plan, $822.8K in salary, $2.8M in stock awards and $21K in other compensation.
Rankings
In 2021, Daniel Van Plew's compensation ranked 1,260th out of 12,404 executives tracked by ExecPay. In other words, Van Plew earned more than 89.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,260 out of 12,404 | 90th |
Division Manufacturing | 447 out of 5,494 | 92nd |
Major group Chemicals And Allied Products | 163 out of 2,369 | 93rd |
Industry group Drugs | 135 out of 2,090 | 94th |
Industry Pharmaceutical Preparations | 89 out of 1,537 | 94th |
Source: SEC filing on April 21, 2022.
Van Plew's colleagues
We found five more compensation records of executives who worked with Daniel Van Plew at Regeneron Pharmaceuticals in 2021.
2021
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
2021
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
2021
Joseph LaRosa
Regeneron Pharmaceuticals
General Counsel
2021
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2021
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019